Published online Aug 27, 2026. doi: 10.4240/wjgs.120918
Revised: June 18, 2026
Accepted: July 14, 2026
Published online: August 27, 2026
Processing time: 158 Days and 10 Hours
Perineal small bowel fistula (PSF) is a highly debilitating complication of radical pelvic malignancy resections. It is typically driven by empty pelvis syndrome (EPS) and chronic adhesive disease. Current therapeutic guidelines lack standar
To evaluate an etiology-driven surgical algorithm, where procedures are chosen based on the underlying mechanism, aiming to improve closure rates.
Retrospective cohort analysis was performed on 28 consecutive patients who un
The study cohort (mean age 56.6 years) included patients with rectal (35.7%), gynecological (35.7%), and various other pelvic malignancies. There were no significant baseline demographic differences between the groups. A significant correlation was observed between fistula etiology and surgical strategy (P = 0.02). While reconstruction was the exclusive surgical approach for patients with EPS (100%), plication was predominantly utilized for cases of tumor recurrence (66.7%). The overall fistula closure rate was 89.3% (25/28), showing no significant difference between group 1 (86.7%) and group 2 (92.3%; P = 1.0). However, group 2 experienced a significantly longer mean time to postoperative flatus (6.8 days vs 4.2 days; P = 0.002). The median follow-up time for the entire cohort was 34.5 months (range: 9.0-107.0 months). Overall survival was comparable across the two surgical groups (32.0 mon
Managing complex PSFs requires a tailored approach. Employing an etiology-driven strategy, specifically pelvic floor reconstruction for structural voids (EPS) and internal intestinal plication for “frozen” adhesive conditions, achieves > 89% closure rates with acceptable morbidity.
Core Tip: This study evaluated an etiology-driven algorithm for repairing perineal small bowel fistulas. By customizing surgical interventions - such as pelvic floor reconstruction and intestinal plication - to the underlying mechanisms of the fistula, researchers achieve a successful closure rate of 89.3% in high-risk patients with a history of pelvic cancer.